<DOC>
	<DOCNO>NCT00401986</DOCNO>
	<brief_summary>The primary purpose study gather additional safety data subject treat Alair System ( hereinafter , `` Alair-Treated Subjects '' ) previously complete one-year study entitle : `` Multicenter Randomized Clinical Trial Bronchial Thermoplasty Alair System Treatment Severe Asthma '' ( Protocol # 0903-27 ) sponsor Asthmatx , Inc . Subjects elect participate safety study follow additional four ( 4 ) year period beyond PREDECESSOR STUDY 'S one-year endpoint .</brief_summary>
	<brief_title>RISA Extension Study - Long Term Safety</brief_title>
	<detailed_description>This multicenter study conduct clinical site participate PREDECESSOR STUDY . Enrollment limited subject treat Alair System PREDECESSOR STUDY . Written , inform consent obtain subject prior perform study procedure . The present study extend follow-up evaluation Alair-Treated Subjects PREDECESSOR STUDY 5 year post-treatment Alair System . These evaluation consist four study visit correspond two-year , three-year , four-year five-year time point follow completion Alair treatment PREDECESSOR STUDY . For consistency PREDECESSOR STUDY , ideally subject 's drug therapy continue consistent GINA Guidelines severity subject 's asthma . Any change maintenance level asthma medication document . The goal follow-on study enroll Alair-Treated Subjects complete PREDECESSOR STUDY . Inclusion subject treatment arm allow well assessment long-term safety Alair procedure .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<criteria>Subject participate PREDECESSOR STUDY entitle `` Multicenter Randomized Clinical Trial Bronchial Thermoplasty Alairâ„¢ System Treatment Severe Asthma '' ( Protocol # 090327 ) . Subject treat Alair System ( `` Alair Group '' ) PREDECESSOR STUDY . Subject able read , understand , provide write Informed Consent . Subject able comply study protocol , include requirement take abstaining medication , complete study require visit . Subject participate another clinical trial involve respiratory intervention could affect outcome measure study , either within 6 week study enrollment , study period . Subject newly diagnose ( since exit PREDECESSOR STUDY ) psychiatric disorder judgment investigator could interfere provision inform consent , completion test , therapy , followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Refractory Asthma</keyword>
	<keyword>Bronchial Thermoplasty</keyword>
	<keyword>Alair System</keyword>
	<keyword>RISA ( Research Severe Asthma )</keyword>
</DOC>